Silymarin for COPD: A Study on Breathing and Quality of Life
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether adding silymarin (a herbal supplement from milk thistle) to your regular COPD treatment can improve your lung function, reduce stress in your body, and help you feel better day-to-day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of COPD confirmed by a breathing test (FEV1/FVC less than 0.7).
- You are between 40 and 80 years old.
- You have not had a COPD flare-up or been in the hospital for one in the last month.
- You do not have asthma, bronchiectasis, lung scarring, tuberculosis, or lung cancer.
- You do not have diabetes, liver disease, heart disease, kidney stones, kidney disease, hyperparathyroidism, or other cancers.
- You have not used antioxidant supplements like vitamins C, E, or N-acetylcysteine in the last month, and you are not allergic to silymarin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether vitamin C supplements can improve health in people with COPD. It aims to see if the antioxidant effects of vitamin C help manage the disease and slow its progression.
This study tests whether taking a probiotic can improve symptoms, lung function, and inflammation in people with COPD. It is for adults with stable COPD who have not had a flare-up or treatment change in the last two months.
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
This trial tests whether increasing omega-3 (from diet and/or supplements) helps people with COPD. It enrolls people with low omega-3 intake and asks them to follow a specific dietary plan during the study.
This Phase 2 trial tests whether sildenafil tablets can improve exercise ability, shortness of breath, and heart-lung function in people with COPD. It also compares against people without COPD to better understand how sildenafil affects breathing tests.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.